HIGHLIGHTS
- who: Marco Troisi from the Institut National de recherche pour l`environnement (INRAE), France Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy have published the paper: A new dawn for monoclonal antibodies against antimicrobial resistant bacteria, in the Journal: (JOURNAL)
- what: With the main aim of increasing the efficacy of therapeutic mAbs against bacterial targets, many efforts were recently made. The approach developed in October 2022 by Chidyausiku and coworkers aimed to overcome the limits of mAb engineering by designing antibody-like scaffolds, not produced in nature, to graft loops frontiersin.org . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.